For instance, metabolic studies have typically not been assessing cognitive function in their studied subjects, and to the best of our knowledge more advanced metabolic studies (like the insulin clamp in conjunction with [18F]-FDG-PET imaging) have never been applied in complying subjects with MCI or AD. This evidence concerns the gene INS and Alzheimer disease.